Virtu Financial LLC Assembly Biosciences, Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$0.8 - $1.74 $9,539 - $20,747	11,924 New	11,924 $10,000
Q3 2022 Nov 07, 2022	BUY	$1.7 - $20.52 $51,078 - $616,543	30,046 New	30,046 $49,000
Q1 2022 May 17, 2022	SELL	$1.46 - $2.45 $52,032 - $87,315	-35,639 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$2.13 - $3.46 $75,911 - $123,310	35,639 New	35,639 $83,000
Q3 2021 Nov 12, 2021	SELL	$3.14 - $3.9 $201,022 - $249,678	-64,020 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$3.8 - $4.56 $243,276 - $291,931	64,020 New	64,020 $248,000
Q2 2020 Aug 07, 2020	SELL	$14.57 - $23.96 $161,435 - $265,476	-11,080 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$8.36 - $23.81 $92,628 - $263,814	11,080 New	11,080 $227,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.